Huang Su, Yifan Chen, Xuyang Zhao, Zengyi Lu, Tongxuan Wei, Qinguo Liu, Xiyang Liu, Qinhao Zhang, Siqi Bian, Qianwei Qiu, Panzhu Yao, Wenlang Liu, Zheng Zheng, Da Xu and Liqin Zhang

Chem, 2025, 11, 102408
DOI: 10.1016/j.chempr.2024.102408

Decoy-PROTAC for specific degradation of “Undruggable” STAT3 transcription factor

Shiqing Li, Xin Wang, Jiabao Huang, Xiuping Cao, Yana Liu, Shiyan Bai, Tao Zeng, Qi Chen, Chunsen Li, Chunhua Lu and Huanghao Yang

Cell Death Dis, 2025, 16
DOI: 10.1038/s41419-025-07535-x

Highly Specific Cytokine Receptor‐Targeting Chimeras for Targeted Membrane Protein Degradation and Sensitization of Osimertinib in EGFR‐Mutated Non‐Small‐Cell Lung Cancer

Jiawei Wu, Qianqian Gao, Qing Xia, Yaru Wang, Zixuan Zheng, Axin He, Yu Liu, Yang Yang, Yanyan Miao and Da Han

Advanced Materials, 2025, 37
DOI: 10.1002/adma.202504050

Redox regulation: mechanisms, biology and therapeutic targets in diseases

Bowen Li, Hui Ming, Siyuan Qin, Edouard C. Nice, Jingsi Dong, Zhongyan Du and Canhua Huang

Sig Transduct Target Ther, 2025, 10
DOI: 10.1038/s41392-024-02095-6

Recent advances in degraders engaging lysosomal pathways and related nanomedicine

Runxin Lu, Xiaofeng Ni, Sha Diao, Yong Wu and Lingli Zhang

European Journal of Medicinal Chemistry, 2025, 292, 117701
DOI: 10.1016/j.ejmech.2025.117701

Receptor-ligand interactions for optimized endocytosis in targeted therapies

Yejin Sung, Youngjin Choi, Eun Sun Kim, Ju Hee Ryu and Ick Chan Kwon

Journal of Controlled Release, 2025, 380, 524
DOI: 10.1016/j.jconrel.2025.01.060

Protein-Based Degraders: From Chemical Biology Tools to Neo-Therapeutics

Lisha Ou, Mekedlawit T. Setegne, Jeandele Elliot, Fangfang Shen and Laura M. K. Dassama

Chem. Rev., 2025, 125, 2120
DOI: 10.1021/acs.chemrev.4c00595

Ferroptosis: principles and significance in health and disease

Fangquan Chen, Rui Kang, Daolin Tang and Jiao Liu

J Hematol Oncol, 2024, 17
DOI: 10.1186/s13045-024-01564-3

Unconventional PROTACs for Targeted Protein Degradation in Cancer Therapy

Xu Zhang, Zhangzhi Song, Xinyu Zhang, Jianhua Zou, Guocan Yu, Xiaoyuan Chen and Sheng Wang

Angew Chem Int Ed, 2025, 64
DOI: 10.1002/anie.202507702

Dehydroabietylamine exerts antitumor effects by affecting nucleotide metabolism in gastric cancer

Jingsong Ma, Jiabao Zhao, Zhengxin Wu, Jinshui Tan, Meijuan Xu, Wenjie Ye, Mengya Zhong, Yubo Xiong, Guangchao Pan, Huiwen Zhou, Shengyi Zhou and Xuehui Hong

Carcinogenesis, 2024, 45, 759
DOI: 10.1093/carcin/bgae037

Proteolysis-targeting chimera-doxorubicin conjugate nanoassemblies for dual treatment of EGFR-TKI sensitive and resistant non-small cell lung cancer

Junhui Ma, Ruixue Zhu, Meijing Li, Hui Jiao, Sijun Fan, Xiang Ma and Guangya Xiang

Acta Biomaterialia, 2025, 195, 421
DOI: 10.1016/j.actbio.2025.02.012

Phenotypic Screening for Targeted Protein Degradation: Strategies, Challenges, and Emerging Opportunities

Baoli Ding, Jiawen Hu, Binyan Shou, Li Jiang, Bo Yang, Ji Cao and Cheng-Liang Zhu

J. Med. Chem., 2025, 68, 18024
DOI: 10.1021/acs.jmedchem.5c00949

Emerging Concepts of Targeted Protein Degrader Technologies via Lysosomal Pathways

Mohammad Maqusood Alam, Sobia Wasim and Sang-Yoon Lee

IJMS, 2025, 26, 5582
DOI: 10.3390/ijms26125582

Expanding TPD Horizons: Innovative Strategies Targeting BCL6 and SMARCA2

Robert B. Kargbo

ACS Med. Chem. Lett., 2024, 15, 576
DOI: 10.1021/acsmedchemlett.4c00166

Boosting Brain Clean-Up: Can Targeting UPS Genes Offer Neuroprotection?

Ashi Mannan, Akhil Sharma and Thakur Gurjeet Singh

Mol Neurobiol, 2025
DOI: 10.1007/s12035-025-05263-z

Unraveling the role of ubiquitin-conjugating enzyme 5 (UBC5) in disease pathogenesis: A comprehensive review

Jin-Jin Shi, Ru-Yi Chen, Yan-Jun Liu, Chang-Yun Li, Jing Yu, Fei-Yang Tu, Jian-Xiang Sheng, Jian-Fei Lu, Le-Le Zhang, Guan-Jun Yang and Jiong Chen

Cellular Signalling, 2024, 124, 111376
DOI: 10.1016/j.cellsig.2024.111376

Sortilin‐Mediated Rapid, Precise and Sustained Degradation of Membrane Proteins via mRNA‐Encoded Lysosome‐Targeting Chimera

Xin Chang, Xinyu Qiu, Xiaoning Tong, Shaoju Gan, Weicheng Yi, Sitao Xie, Xiangsheng Liu, Chao Zuo and Weihong Tan

Advanced Science, 2025, 12
DOI: 10.1002/advs.202501222

Transforming Therapeutic Approaches with PROTAC Technology: New Targets and Potentials

Robert B. Kargbo

ACS Med. Chem. Lett., 2024, 15, 573
DOI: 10.1021/acsmedchemlett.4c00165

A DNA-Mediated Lysosomal Degradation Strategy for Targeted Degradation of PD-L1 Protein

Wenjing Huang, Can Yang, Sizhu Cheng, Shuyue Fu, Xinyu Chen, Yaojin Zhu, Honggang Hu, Fei Gao and Shipeng He

J. Med. Chem., 2025, 68, 11829
DOI: 10.1021/acs.jmedchem.5c00675

The scaffold protein DLG4 facilitates RNF63-mediated ubiquitination and degradation of STAT3 in non-small cell lung cancer

Shisong Chen, Hongjie Xu, Ning Li, Yang Yang, Ruxi Pang, Shuwei Zhang, Junjie Qiao and Hao Chen

Cell Commun Signal, 2025, 23
DOI: 10.1186/s12964-025-02334-5

Next steps for targeted protein degradation

Mackenzie W. Krone and Craig M. Crews

Cell Chemical Biology, 2025, 32, 219
DOI: 10.1016/j.chembiol.2024.10.004

Targeting mitochondria with natural polyphenols for treating Neurodegenerative Diseases: a comprehensive scoping review from oxidative stress perspective

Yueyue Guan, Lei Li, Rui Yang, Yun Lu and Jun Tang

J Transl Med, 2025, 23
DOI: 10.1186/s12967-025-06605-0

Pathogenic missense variants of CSNK2B associated with Poirier-Bienvenu neurodevelopmental disorder impact differently on CK2 holoenzyme formation

Hanna Kavaliova, Barbara Lecis, Demetra Ballardin, Laetitia Cobret, Thierry Bienvenu, Severine Morisset-Lopez and Heike Rebholz

Biological Chemistry, 2025, 406, 139
DOI: 10.1515/hsz-2024-0162

Aptamer‐based Immune Checkpoint Inhibition for Cancer Immunotherapy

Yihao Huang, Guihong Lin, Sinong Liu, Mingying Chen, Chaoyong Yang and Yanling Song

ChemBioChem, 2025, 26
DOI: 10.1002/cbic.202400599

Versatile One-Pot Synthesis of Hydrophobic Tags by Multicomponent Reactions

Federica Carolina Balestrero, Laura Gioiello, Georgia Goutsiou, Sabina Sangaletti, Rita Maria Concetta Di Martino, Fabrizio Condorelli, Ambra A. Grolla and Tracey Pirali

ACS Omega, 2025, 10, 4745
DOI: 10.1021/acsomega.4c09726

GPC3-mediated lysosome-targeting chimeras (GLTACs) for targeted degradation of membrane proteins

Yuxin Fang, Yaojin Zhu, Wei Wang, Zhewei Xia, Shipeng He, Guoqiang Dong and Chunquan Sheng

Acta Pharmaceutica Sinica B, 2025, 15, 2156
DOI: 10.1016/j.apsb.2025.02.037

Targeted protein degradation technologies: Emerging mechanisms and nano-based innovations

Mingge Hou, Runze Zhao, Shenghui Wang, Bing Jiang and Xiyun Yan

Nano Research, 2025, 18, 94907983
DOI: 10.26599/NR.2025.94907983

WTAP Mediated m6A Modification Stabilizes PDIA3P1 and Promotes Tumor Progression Driven by Histone Lactylation in Esophageal Squamous Cell Carcinoma

Tao Huang, Qi You, Jiawei Liu, Xuguang Shen, Dengjun Huang, Xinlu Tao, Zhijie He, Chengwei Wu, Xinran Xi, Shouqiang Yu, Feng Liu, Zhihao Wu, Wenjun Mao and Shaojin Zhu

Advanced Science, 2025, 12
DOI: 10.1002/advs.202506529